Literature DB >> 8226418

Susceptibility of alpha-haemolytic streptococci causing endocarditis to benzylpenicillin and ten cephalosporins.

M H Wilcox1, T G Winstanley, C W Douglas, R C Spencer.   

Abstract

A clinical case of streptococcal endocarditis in which the isolate proved susceptible to third- but not first-generation cephalosporins prompted us to examine the susceptibility of 44 alpha-haemolytic streptococci from cases of endocarditis to ten cephalosporins and benzylpenicillin. Twenty per cent of strains were resistant to penicillin, and 20% were tolerant. Cefazolin, cefuroxime and cefpirome were the most active first-, second- and third-generation cephalosporins tested. Other first-generation cephalosporins tested compared poorly to cefazolin. Cefotaxime and cefpirome were moderately active against some penicillin-resistant strains. Penicillin tolerance was common in Streptococcus gordonii, but a correlation between tolerance and dextran production could not be confirmed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226418     DOI: 10.1093/jac/32.1.63

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.

Authors:  S J Rosser; M J Alfa; S Hoban; J Kennedy; G K Harding
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

2.  Contribution of phosphoglucosamine mutase to determination of bacterial cell morphology in Streptococcus gordonii.

Authors:  Kisaki Shimazu; Yukihiro Takahashi; Hiroyuki Karibe; Fusako Mitsuhashi; Kiyoshi Konishi
Journal:  Odontology       Date:  2011-05-13       Impact factor: 2.634

Review 3.  Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.

Authors:  L R Wiseman; H M Lamb
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

4.  Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.

Authors:  E Cercenado; M D Díaz; C Sánchez-Carrillo; T Vicente; J C Bernaldo de Quirós
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.